The Centre for Pharmaceutical Oncology offers undergraduate and graduate education courses and research training offerings pertaining to its mission to train the pharmaceutical oncology scientists of the future.
A bi-monthly seminar series features speakers with research interests covering the broad pharmaceutical oncology landscape.
CPO Seminar Series Schedule 2024
Date |
Time |
Speaker |
Title |
Zoom Link |
---|---|---|---|---|
January 25, 2024 |
11:00am EST |
Dr. Sarah Cheal |
DOTA Ligand Bound Radionuclide-Based Pre-targeted Radioimmunotherapy |
|
February 1, 2024 |
11:00am EST |
Dr. Anne Carpenter |
Insights from images: microscopy data for drug discovery |
|
February 15, 2024 |
10:00am EST |
Dr. Jolanta Kunikowska |
Treatment of Glioma with Radiolabeled Substance-P and PSMA |
|
February 29, 2024 |
11:00am EST |
Dr. Maximilian Reichert |
Unraveling Pancreatic Tumor Heterogeneity for Targeted Therapies |
|
March 14, 2024 |
12:00pm EST |
Dr. Douglas Hanahan |
Mechanisms and therapeutic targeting of the immuno-evasive tumor microenvironment |
|
March 28, 2024 |
11:00am EST |
Dr. Paul Hergenrother |
Anticancer Drug Discovery, from Pets to People |
|
April 25, 2024 |
11:00am EST |
Dr. Christian Badr |
Stress Signaling in Glioblastoma Pathogenesis, Metabolism, and Response to Therapy |
|
May 9, 2024 |
|
|
|
|
May 23, 2024 |
|
|
|
|